Suppliers / Huadong Medicine (Xi'An) Bodyguard Pharmaceutical

Huadong Medicine (Xi'An) Bodyguard Pharmaceutical

China Updated 9 July 2026

Huadong Medicine (Xi'An) Bodyguard Pharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files across a filed portfolio of 3 molecules.

4
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Olaparib US FDA 2
Brexpiprazole US FDA 1
Topiramate US FDA 1

Also appears on these molecule pages

Questions about Huadong Medicine (Xi'An) Bodyguard Pharmaceutical

Does Huadong Medicine (Xi'An) Bodyguard Pharmaceutical hold a US DMF or a CEP?
Huadong Medicine (Xi'An) Bodyguard Pharmaceutical holds 4 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Huadong Medicine (Xi'An) Bodyguard Pharmaceutical make?
3 molecules are on record against Huadong Medicine (Xi'An) Bodyguard Pharmaceutical, including Olaparib, Brexpiprazole and Topiramate. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Huadong Medicine (Xi'An) Bodyguard Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability